| $687M | ||
| $385M | ||
| $215M | ||
| $100M | ||
| $94M | ||
| $82M |
Buys | $34,625 | 5 | 100 |
Sells | $0 | 0 | 0 |
| DODD DAVID A | President, CEO | 1 | $10,800 | 0 | $0 | $10,800 |
| SPENCER JOHN N JR | director | 1 | $9,800 | 0 | $0 | $9,800 |
| Reynolds Mark | CFO | 1 | $7,343 | 0 | $0 | $7,343 |
| Sharkey John W. | VP, Business Development | 1 | $5,940 | 0 | $0 | $5,940 |
| McKee Kelly T. Jr. | Chief Medical Officer | 1 | $742 | 0 | $0 | $742 |
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; Centers for Disease Control and Prevention; U.S. Department of Defense; Emory University; University of Pittsburgh; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is based in Smyrna, Georgia.
Over the last 12 months, insiders at GeoVax Labs, Inc. have bought $34,625 and sold $0 worth of GeoVax Labs, Inc. stock.
On average, over the past 5 years, insiders at GeoVax Labs, Inc. have bought $43,299 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: DODD DAVID A (President, CEO) — $10,800. SPENCER JOHN N JR (director) — $9,800. Reynolds Mark (CFO) — $7,343.
The last purchase of 1,107 shares for transaction amount of $742 was made by McKee Kelly T. Jr. (Chief Medical Officer) on 2025‑08‑07.
| 2025-08-07 | McKee Kelly T. Jr. | Chief Medical Officer | 1,107 0.0044% | $0.67 | $742 | -17.09% | ||
| 2025-04-10 | SPENCER JOHN N JR | director | 10,000 0.0744% | $0.98 | $9,800 | -27.65% | ||
| 2025-04-10 | Sharkey John W. | VP, Business Development | 6,000 0.0451% | $0.99 | $5,940 | -27.65% | ||
| 2025-04-01 | DODD DAVID A | President, CEO | 10,000 0.0723% | $1.08 | $10,800 | -35.44% | ||
| 2025-03-31 | Reynolds Mark | CFO | 6,800 0.0501% | $1.08 | $7,343 | -34.21% | ||
| 2024-08-09 | DODD DAVID A | President, CEO | 8,000 0.1589% | $1.95 | $15,600 | -6.95% | ||
| 2024-02-22 | DODD DAVID A | President, CEO | 8,209 0.431% | $2.27 | $18,663 | -3.42% | ||
| 2024-02-21 | DODD DAVID A | President, CEO | 520 0.0257% | $2.15 | $1,118 | -3.64% | ||
| 2024-02-07 | Reynolds Mark | CFO | 2,000 0.0718% | $2.77 | $5,540 | -15.89% | ||
| 2023-12-22 | McKee Kelly T. Jr. | Chief Medical Officer | 6,944 0.0257% | $0.36 | $2,500 | -58.12% | ||
| 2023-09-25 | McKee Kelly T. Jr. | Chief Medical Officer | 9,653 0.0371% | $0.52 | $5,020 | -63.43% | ||
| 2023-08-25 | DODD DAVID A | President, CEO | 35,087 0.1351% | $0.57 | $20,000 | -64.70% | ||
| 2023-08-18 | Reynolds Mark | CFO | 10,000 0.038% | $0.52 | $5,179 | -61.64% | ||
| 2023-04-24 | DODD DAVID A | President, CEO | 32,000 0.122% | $0.64 | $20,445 | -18.34% | ||
| 2023-04-20 | Reynolds Mark | CFO | 8,000 0.0297% | $0.63 | $5,040 | -19.13% | ||
| 2022-09-21 | CHASE RANDAL D | director | 10,000 0.043% | $1.10 | $11,000 | -39.45% | ||
| 2022-07-01 | Sharkey John W. | VP, Business Development | 1,000 0.0043% | $0.82 | $820 | -6.46% | ||
| 2022-06-27 | McKee Kelly T. Jr. | Chief Medical Officer | 4,464 0.0367% | $1.12 | $5,000 | -28.66% | ||
| 2022-06-21 | CHASE RANDAL D | 10,000 0.0761% | $1.21 | $12,100 | -38.29% | |||
| 2022-05-05 | McKee Kelly T. Jr. | Chief Medical Officer | 9,722 0.0758% | $0.72 | $7,000 | +11.57% |
| DODD DAVID A | President, CEO | 36661 0.1446% | $6,071.06 | 10 | 0 | <0.0001% |
| Reynolds Mark | CFO | 14013 0.0553% | $2,320.55 | 10 | 0 | <0.0001% |
| SPENCER JOHN N JR | director | 11402 0.045% | $1,888.17 | 5 | 0 | |
| Sharkey John W. | VP, Business Development | 6191 0.0244% | $1,025.23 | 2 | 0 | <0.0001% |
| McKee Kelly T. Jr. | Chief Medical Officer | 3494 0.0138% | $578.61 | 6 | 0 | <0.0001% |
| EMORY UNIVERSITY | 10 percent owner | 231070253 911.1774% | $38.27M | 0 | 24 | |
| ROBINSON HARRIET L | CSO Emeritus | 1201226 4.7368% | $198,923.03 | 5 | 8 | |
| Tsolinas Peter M | director | 431734 1.7025% | $71,495.15 | 1 | 0 | |
| CHASE RANDAL D | director | 36613 0.1444% | $6,063.11 | 2 | 0 | <0.0001% |
| HILDEBRAND DONALD G | director | 19000 0.0749% | $3,146.40 | 1 | 0 | |
| MCNALLY ROBERT T | director | 8300 0.0327% | $1,374.48 | 7 | 0 | |
| NEWMAN MARK J | Chief Scientific Officer | 3000 0.0118% | $496.80 | 1 | 0 |
$1,029,337 | 36 | -28.38% | $5.96M | |
$1,138,733 | 28 | -4.94% | $3.57M | |
$29,635,355 | 27 | 9.05% | $5.77M | |
$547,862 | 19 | -29.82% | $3.48M | |
$337,688 | 19 | -33.30% | $3.69M | |
GeoVax Labs, Inc. (GOVX) | $138,573 | 16 | -25.71% | $4.2M |
$1,556,551 | 15 | -25.43% | $5.81M | |
$8,079,884 | 14 | -43.20% | $2.62M | |
$389,864 | 11 | 12.52% | $4.81M | |
$105,917 | 11 | -28.06% | $2.87M | |
$18,269 | 10 | -21.15% | $3.12M | |
$90,087 | 9 | 20.06% | $3.74M | |
$8,971,546 | 8 | 6.18% | $5.51M | |
$211,895 | 8 | -39.70% | $6.3M | |
$245,000 | 7 | -62.00% | $4.64M | |
$726,438 | 4 | -72.85% | $2.42M | |
$149,778 | 4 | -45.16% | $5.48M | |
$4,423 | 2 | 3.27% | $5.81M | |
$37,000 | 1 | 79.42% | $3.46M |
| Increased Positions | 0 | 0% | 0 | 0% |
| Decreased Positions | 0 | 0% | 0 | 0% |
| New Positions | 0 | New | 0 | New |
| Sold Out Positions | 0 | Sold Out | 0 | Sold Out |
| Total Postitions | 0 | 0% | 0 | 0% |
| Sabby Management, Llc | $137.00 | 1.54% | 661,376 | +661,376 | New | 2025-09-30 |
| Armistice Capital, Llc | $111.00 | 1.24% | 533,897 | +533,897 | New | 2025-09-30 |
| Vanguard Group Inc | $51.00 | 0.57% | 244,163 | +129,007 | +112.03% | 2025-09-30 |
| Geode Capital Management, Llc | $43.00 | 0.48% | 207,074 | +100,119 | +93.61% | 2025-09-30 |
| Hudson Bay Capital Management Lp | $21.00 | 0.23% | 100,000 | +100,000 | New | 2025-09-30 |
| Ubs Group Ag | $12.00 | 0.14% | 58,428 | -141,829 | -70.82% | 2025-09-30 |
| Blackrock, Inc. | $6.00 | 0.06% | 27,565 | 0 | 0% | 2025-09-30 |
| Morgan Stanley | $5.00 | 0.06% | 25,120 | -25,000 | -49.88% | 2025-09-30 |
| Moneta Group Investment Advisors Llc | $4.00 | 0.05% | 20,000 | +10,000 | New | 2025-09-30 |
| State Street Corp | $3.00 | 0.04% | 16,828 | 0 | 0% | 2025-09-30 |